Archive

Category Archives for "Cancer News"

JAK Mutations a Possible Indicator of Drug Resistance

JAK mutations

JAK Mutations are genetic abnormalities that affect the production of red blood cells. They are often found in individuals with polycythemia vera, as well as a number of other myeloproliferative neoplasms. The anti-PD-1 agent, Keytruda (pembrolizumab) was approved in 2014 by the U.S. Food and Drug Administration for the treatment of advanced melanoma. Since then, it has received […]

Continue reading

CHIPSA Hospital Files Patent on Cancer Immunotherapy Combination of Checkpoint Inhibitors and Coley Vaccine

Preclinical and Clinical Data Support Efficacy of Novel Approach to Cancer Immunotherapy Developed by CHIPSA Hospital CHIPSA Hospital, dedicated to the accelerated development of nontoxic cancer immunotherapies announced today filing of a patent application covering the combination of FDA approved antibodies known as “checkpoint inhibitors” together with Coley Vaccine, a stimulatory of innate immunity. CHIPSA […]

Continue reading

Could Nano Drugs Be a New Alternative Cancer Treatment?

Nano Drugs

Treatments against cancerous tumors have always been a dangerous and complicated process. These cancer cells can grow and spread rapidly. In addition, the current available treatments are determined by whether or not the patient can endure the treatment process, and also the location of the tumor. Scientists are now exploring Nano drugs. With the options […]

Continue reading

Steep Rise in Prices of Older Cancer Drugs

Prices of Older Cancer Drugs

The study included oral and intravenous chemotherapy cancer drugs covered by Medicare Part B. Medicare is the federal health insurance plan for people 65 or older. “Higher costs lead to higher copays,” said study co-author Dr. Sham Mailankody. He’s a medical oncologist at Memorial Sloan Kettering Cancer Center in New York City. “And empiric research […]

Continue reading